Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$61,367,885
-$15,197,113 QoQ
Shares Held
485,736
-11.6% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#190
of 2,266 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $994,368,960 across 9 Drug Manufacturers - General names. GILD ranks #7 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,376,588 | $346,404,603 | |
| 2 | LLY |
ELI LILLY & Co
|
119,698 | $143,569,383 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,050,056 | $134,932,195 | |
| 4 | JNJ |
Johnson & Johnson
|
524,387 | $133,178,566 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,141,710 | $65,785,328 | |
| 6 | PFE |
Pfizer Inc
|
2,723,573 | $65,583,636 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
485,736 | $61,367,885 | |
| 8 | AZN |
Astrazeneca PLC
|
157,316 | $29,830,259 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,367,885 | 485,736 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $76,564,998 | 549,365 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $73,315,669 | 597,325 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $70,699,785 | 636,935 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $95,156,837 | 858,274 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $12,890,119 | 115,039 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $1,142,906 | 13,632 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,071,961 | 15,624 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $65,044,387 | 887,978 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $60,601,230 | 748,071 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $37,501,399 | 500,419 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $42,582,098 | 552,512 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $47,513,681 | 572,661 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $74,340,862 | 865,939 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $55,407,242 | 898,156 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,966,072 | 921,632 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $49,057,841 | 825,195 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $51,480,489 | 709,000 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $40,870,422 | 585,117 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $41,324,951 | 600,130 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||